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Abstract
BCG vaccine drives a strong T helper 1 cellular immunity which is essential for the protection against mycobacteria, however
recent studies suggest that BCG vaccination can have non-specific beneficial effects unrelated to tuberculosis. In the present
cohort study the development of cytokine profiles following BCG vaccination was investigated. Immune responses to PPD
were assessed before vaccination and at ages of 5 months, 1 year, and 2 years, followed by BCG scar measurement at 4
years of age. BCG was shown to induce both Th1 and Th2 type responses against PPD at about 5 months of age after
vaccination, and while Th1 response was sustained, Th2 responses declined over time. However, BCG scar size was strongly
correlated with Th2 responses to PPD at 5 months of age. Importantly, we observed no clear effects of BCG vaccination on
innate immune responses in terms of early IL-10 or TNF-a production whereas some alterations in general adaptive immune
responses to PHA were observed.
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Introduction
Most immunological studies on the efficacy of Bacille Calmette-
Gue ´rin (BCG) vaccination focus on the production of IFN-c as the
main feature of Th1 response, which leads to the activation of
important cells such as macrophages to contain mycobacteria.
Besides the partial protection against TB through IFN-c
production [1], BCG may decrease the mortality and morbidity
in childhood and adulthood by its non-specific effects on the
immune system [2,3]. The presence or absence of BCG scar has
been used as one of the indicators for successful vaccination [4],
while not necessarily correlated with protection against tubercu-
losis [5], studies in Guinea Bissau have shown better survival and
less respiratory infections in children with BCG scars [6,7]. These
observations on the impact of BCG has been proposed to be
caused by the enhancement of the maturation of the innate and
adaptive immune responses [8]. However, very few studies have
examined whether BCG vaccination in childhood alters not only
responses to mycobacterial antigens, but also to mitogens or to
stimuli of the innate immune system. Moreover, environmental
factors can affect neonatal immune responses, influencing both
specific and non-specific immune reactivities. Factors such as
living on traditional farms or parasitic infections are known to
affect the immune system in early life with possible consequences
for disease outcome later in life [9,10] or for responses to
vaccination at infancy [11]. Indeed, it is known that chronic
helminth infection can modulate immune responses of the host to
produce more Th2 and regulatory cytokines against helminth and
bystander antigens. In developing countries, infants can be
exposed to helminth antigens from early life, even in utero, which
may affect the child’s subsequent immune responses to Th-1
producing vaccines such as BCG [11,12]. There are so far very
few studies that have examined the development and progression
of cellular immune responses following BCG vaccination of
neonates over time and the effect that environmental factors
may have on this process.
In the current longitudinal study following BCG vaccination of
neonates in Indonesia, we have examined the production of Th1
(IFN-c) and Th2 (IL-5, IL-13) cytokines in day 6 supernatants of
whole blood in response to PPD and PHA to determine specific
and non-specific adaptive immune responses. To assess the effect
of BCG vaccination on the development of innate immune
responses, IL-10 and TNF-a were measured in one day culture
supernatants of whole blood stimulated with LPS and PPD. We
also analyzed the relationship between cytokine responses to
mycobacterial antigens and scar formation at an age when the scar
formation has stabilized. In order to assess how external factors
might influence responses to BCG vaccination, we studied the
effect of maternal parasitic infection status on the profile of
cytokine production over time.
Methods
Ethics Statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The study was approved by Ethics
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mothers provided written informed consent for the collection of
samples from their children and for subsequent analysis.
2.1. Blood collection, BCG vaccination and measurement
of BCG scar
This study was performed as part of a birth cohort to examine
the development of immune responses of children living in areas
endemic for helminth infection. Maternal parasitological data such
as filarial or intestinal parasite infection was obtained during the
recruitment of pregnant women as described before [13]. Filarial
antigenemia for Wuchereria bancrofti was determined by immuno-
chromatographic test (ICT) as described by the manufacturer
(Binax, Scarborough, ME, USA). The presence of intestinal
helminth eggs and protozoa cysts was determined from direct stool
examination by microscopy, using lugol staining.
Children were recruited from two adjacent villages in a peri-
urban area, after their mothers gave informed consents for
participation in this study. Blood was withdrawn by venipuncturist
and was collected in a heparinized tube at several time points: T0:
before BCG vaccination, T5: 5 months of age, T12: 1 year of age,
T24: 2 years of age. In Indonesia, BCG vaccination is the first
vaccine to be given according to the national vaccination program,
followed by three Hepatitis B vaccination, three diphtheria-
pertusis-tetanus (DPT) that are given together with three oral polio
vaccination, and finally measles vaccination before the child
reaches 1 year of age. BCG vaccination program requires every
infant to be vaccinated soon after birth by health staff from local
primary health care center (PHC). BCG vaccine used here
contains attenuated live Mycobacterium bovis strain Paris No. 1173-
P2 (Biofarma, Bandung, Indonesia), and 0.05 ml is given by
intradermal injection of the arm.
After BCG vaccination, the resulting BCG scars were measured
at 4 years of age by the same person from the research team, and
the mean diameter of scar size was calculated from diameters
perpendicular to each other. The reason for measuring BCG scar
at 4 years of age is because the scar formation is expected to have
stabilized. A BCG scar was considered negative if the mean
diameter was less than 2 mm.
2.2. Whole blood culture
Heparinized venous blood was processed for culture within
6 hours after venipuncture. As previously described [14], the
whole blood was diluted 10 times in RPMI 1640 medium
(Invitrogen, Breda, The Netherlands) and was stimulated with
tuberculin purified protein derivative of Mycobacterium tuberculosis
(PPD) batch RT 50 (10 mg/ml; Statens Serum Institut, Denmark,
Copenhagen), phytohaemagglutinin (PHA; 2 mg/ml; Wellcome
Diagnostics, Dartford, UK), lipopolysaccharide (LPS; 100 ng/ml;
Sigma-Aldrich chemie, Zwijndrecht, The Netherlands) or med-
ium only as a negative control. One hundred microlitres of
stimuli were added to each well containing 100 ml diluted blood
in a round-bottomed 96 well plates (Nunc, Roskilde, Denmark).
LPS stimulation was performed in 101 from 147 samples (69%).
The plates were incubated in the presence of 5% CO2, at 37uC.
Supernatants were collected on day 1 for interleukin (IL)-10
and TNF-a measurement to assess innate immune responses
to LPS and PPD, and on day 6 for IL-5, IL-13, IFN-c mea-
surement to discern antigen specific (PPD) and non-specific
polyclonal (PHA) adaptive immune responses. All supernatants
were kept frozen in 220uC until measurement. The cytokine
measurements were performed by multiplex bead-based assay as
described below.
2.3. Cytokine measurement in supernatants
IL-10, TNF-a, IL-13 and IFN-c levels were measured in
supernatants by in-house multiplex bead based assay using
Luminex IS 100 (Luminexcorp, Austin, TX, USA) while IL-5
level was measured by ELISA as described elsewhere [13]. The
detection limits for IL-10, TNF-a, IL-13, IFN-c and IL-5 were
6.5 pg/ml, 1.7 pg/ml, 12.5 pg/ml, 3.6 pg/ml, 2 pg/ml, respec-
tively. All samples with values below detection limit were given
half of these threshold values.
2.4. Statistical analyses
Cytokine levels were analyzed in two ways, either using raw
cytokine levels when comparing cytokines between two groups of
children or using net cytokine levels (substracted from the negative
control) to obtain percentage of responders/non-responders
(above or below zero for substracted values). Mann-Whitney
non- parametric test was used to compare cytokine levels which
were not normally distributed. Since the sample size in each time
point was not equal, Mann-Whitney test was used to compare
cytokine responses between two time points of measurement. The
correlations between cytokine responses to PPD and PHA and
between BCG scar size and cytokine responses were analyzed
using Spearman’s rank correlation. In order to adjust cytokine
levels for other variables (gender, birth weight, birth season, age
receiving BCG, place of residence, maternal intestinal helminth or
protozoan infection), multiple linear regression was performed
with diameter of BCG scar as the outcome. Age receiving BCG,
diameter of BCG scars and cytokine levels were previously log-
transformed to get a normal distribution. The statistical analyses
were performed in SPSS version 16. A two-tailed p value was
considered significant if less than 0.05.
Results
3.1. Study subjects
A total of 147 children were recruited into the study and blood
samples were obtained before BCG vaccination was given (T0).
From these children, 120 children could be followed up at T5, 105
children at T12 and 98 children at T24. Apart from 66 children in
whom blood samples were available at all time points, there were
81 children in whom blood samples were not available at one or
two follow up time points due to the refusal of parents at the
particular time point to allow blood sampling of their child
(n=14), child discomfort (crying) (n=2), moving out of the study
area (n=5), death of the child (n=1), not able to find the child and
family (n=37), and lack of sufficient blood for whole blood culture
(n=22). There were 6 infants who had received BCG with unclear
dates but before any other vaccination; therefore they were
included in the analysis. From 141 children with known date of
BCG vaccination, the average age at which BCG vaccination was
given was at 5 weeks (IQR=2.0–8.5). Of these, 4 infants (3%)
received BCG at the age of less than 1 week, 63 infants (44%) at
the age between 1 week and 4 weeks, 39 infants (28%) at the age
between 4 weeks and 8 weeks, and 35 infants at the age more than
8 weeks (25%). The mean interval time between BCG vaccination
and blood collection at 5 months of age was 20.1 weeks (SD=5.8
weeks). As shown in Table 1, the child’s characteristics were
similar between those with complete and incomplete cytokine
data. For the comparison of cytokine production before and after
BCG vaccination, we used the data from all children (n=147),
while for the relationship between cytokine data and BCG scar we
analyzed data from children with complete cytokine results
(n=66).
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vaccination: Th1 and Th2 cytokine production in
response to PPD and PHA
In comparison with pre vaccination time point (T0), IFN-c, IL-5
and IL-13 responses to PPD increased after BCG vaccination at 5
months of age (p,0.001 for all cytokines). In contrast to IFN-c
which remained high until the children reached 2 years of age, IL-
5 and IL-13 responses showed a gradual decrease (Figure 1A).
Before BCG vaccination (baseline time point), there were already a
proportion of IFN-c (69%), IL-5 (55%) and IL-13 (36%)
responders to PPD (Figure 1C).
To determine whether BCG vaccination influenced the
polyclonal non-specific responses as well, cytokine production to
PHA was measured. As shown in figure 1B and 1C, the pattern for
IFN-c responses to PHA was increased significantly from pre
vaccination to 2 years of age (p,0.001).
The relations between IFN-c production in response to PPD and
to PHA were analyzed next (Figure 2A). A correlation was seen
before vaccination but this was much stronger at 5 months of age
which was the first time point after vaccination whereas at two years
of age, the IFN-c production in response to PPD was no longer
correlated with IFN-c response to PHA. Regarding Th2 cytokines
(Figure 2B, 2C), before vaccination correlations were weaker than
that observed for IFN-c. After vaccination, at 5 months and 1 year of
age, the IL-5 and IL-13 production in response to PPD and PHA
were correlated to a better extent. However, as for IFN-c at 2 years of
age the Th2 responses to PPD and PHA were no longer correlated.
3.3. Innate immune responses before and after BCG
vaccination: early IL-10 and TNF-a production in
response to PPD and LPS
We were interested in the pro and anti inflammatory innate
immune responses and therefore measured IL-10 and TNF-a in
day 1 supernatants following stimulation of whole blood with PPD
(stimulates TLR2, unpublished data) and LPS (stimulates TLR4).
Compared to T0, no increase and even a tendency for a gradual
decrease over time was observed for IL-10 response to PPD (T5:
p.0.05, T12: p.0.05, T24: p,0.001). Similarly, TNF-a response
to PPD decreased over time up to 2 years of age (T5: p.0.05,
T12: p=0.001, T24: p,0.001) (Figure 3A). When responses to a
classic innate stimulus, LPS, was examined, patterns similar to
innate PPD responses were seen: no increase in IL-10 and TNF-a
responses after vaccination, and a significant decrease in both
cytokines between T0 and T24 (p,0.001) (Figure 3B). It was also
noted that the spontaneous production of IL-10 and TNF-a in day
1 supernatants did not change after vaccination (Table 2).
Table 1. Comparison of child’s characteristics with BCG scar measurement and cytokine data at all time points (complete data),
children with incomplete cytokine data and all children recruited into the study.
Child characteristics All children (n=147)
Children with complete
cytokine data (n=66)
Children with incomplete
cytokine data (n=81)
Place of residence
Jati Sampurna 69 (47%) 34 (52%) 35 (43%)
Jati Karya 78 (53%) 32 (48%) 46 (57%)
Mean birth weight (kg) (SD) 3.2 (0.5) 3.2 (0.4) 3.2 (0.5)
,3 kg 23/99 (23%) 13/50 (26%) 10/49 (20%)
.=3 kg 76/99 (77%) 37/50 (74%) 39/49 (80%)
Birth season
dry season 74 (50%) 39 (59%) 35 (43%)
rainy season 73 (50%) 27 (41%) 46 (57%)
Gender
male 70/141 (50%) 36/66 (54%) 34/75 (45%)
female 71/141 (50%) 30/66 (46%) 41/75 (55%)
Median age at BCG vaccination (week) (IQR) 5 (2.0–8.5)
(n=141)
4 (1.7–8.2)
(n=66)
5 (2.0–9.0)
(n=75)
Mean interval BCG vaccination and T5 (week) (SD) 20.1 (5.8) (n=119) 20.7 (5.7)
(n=66)
19.4 (5.9) (n=53)
Median BCG scar at 48 months (mm) (IQR) 3.3 (2.0–4.5) (n=96) 3.3 (1.5–4.1) (n=58) 3.5 (2.4–4.8) (n=38)
Maternal parasitic infections
Filaria 35/147 (24%) 15/66 (23%) 20/81 (25%)
Intestinal helminth infection 51/139 (37%) 18/65 (28%) 33/74 (45%)
Hookworm 25/139 (18%) 8/65 (12%) 17/74 (23%)
Ascaris lumbricoides 21/139 (15%) 9/65 (14%) 12/74 (16%)
Trichuris trichiura 11/139 (8%) 4/65 (6%) 7/74 (9%)
Intestinal protozoan infection 39/139 (28%) 13/65 (20%) 26/74 (35%)
Blastocystis hominis 31/139 (22%) 10/65 (15%) 21/74 (28%)
Others* 15/139 (11%) 3/65 (5%) 12/74 (16%)
Co-infection of intestinal helminth and protozoan 20/139 (14%) 6/65 (9%) 14/74 (19%)
*other intestinal protozoa species: Entamoeba histolytica/dispar, E. coli, Iodamoeba bu ¨tschlii, E. nana, E. hartmani.
doi:10.1371/journal.pone.0014066.t001
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status and the cytokine responses to PPD and LPS before
vaccination and at different ages after BCG vaccination
Neither filarial infection (data not shown) nor intestinal
helminth infection status of mothers had a clear effect on the
response of children to PPD in terms of Th1, Th2, pro or anti
inflammatory cytokines either at pre or at different ages after
vaccination (Table 3).
Interestingly, children born to mothers infected with intestinal
protozoa in which Blastocystis hominis was the predominant species,
had consistently lower TNF-a production in response to PPD at
Figure 1. Adaptive cytokine responses to PPD and PHA before and after vaccination. IFN-c, IL-5, IL-13 responses to PPD (A) and PHA (B).
Levels of cytokines at T0 (before vaccination, n=143); T5 (5 months of age, n=119), T12 (1 year of age, n=103) and T24 (2 years of age, n=97).The horizontal
lines in the bars represent the median, with the lower 25% and upper 75% percentiles and extended whiskers the 10% and 90% percentiles. Mann-Whitney
test: *0.05.p$0.01; **0.01.p$0.001; ***0.001.p. C: Percentage of PPD and PHA responders. T0: before BCG vaccination, T5: at 5 months of age, T12: at 1 year
of age, and T24: at 2 years of age. A responder in terms of cytokine production in response to a stimuli is defined as producing cytokine after stimulationa b o v e
the background production of cytokine when no stimulus is added (level in a stimulated culture above zero after substraction of background cytokine level).
doi:10.1371/journal.pone.0014066.g001
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compared to the children born to mothers with no protozoan
infections. The same difference was also observed in IL-10
response to PPD at T0 (p,0.01), T5 (p,0.01), and T12
(p=0.071). Regarding innate responses to LPS, only at T0
children from infected mothers showed significantly lower IL-10
production compared to those from non-infected mothers
(p=0.029). When Th1 and Th2 cytokines as adaptive immune
responses were considered, the IFN-c response to PPD at T5
(p=0.036) and the IL-13 response to PPD at T0 (p=0.032) were
significantly lower in children born to mothers infected with
intestinal protozoa (Table 3). Similar results were found when we
compared children from mothers positive for protozoan infection
only, with those from mothers negative for both intestinal
helminth and protozoan infection (data not shown). However
when the children from mothers co-infected with intestinal
helminths and protozoa were compared to those from mothers
negative for both, the differences became less significant especially
after vaccination (Supporting Table 1). Although all findings show
that maternal intestinal parasites may influence the degree of
child’s cytokine production, the pattern of change in any cytokine
pattern over time was not affected (data not shown).
3.5. Immune responses to PPD and the presence or
absence of BCG scar at 4 years of age
Of sixty six children with complete cytokine data at all time
points, there were 58 children with BCG scar measurement at 4
years of age. Since BCG vaccination increased the IFN- c, IL-5
and IL-13 responses to PPD but not the innate responses as shown
in IL-10 or TNF-a responses to PPD, we show the production of
IFN- c and IL-5 in 15 vaccinated children with no BCG scar
(,2 mm) and 43 children with a positive BCG scar ($2 mm)
(Figure 4A, 4B). It is clear that some of the children with no BCG
scar were still producing cytokines in response to PPD. The
cytokine production at 5 months of age, correlated significantly
with BCG scar size measured at 4 years of age: IL-5 response to
PPD (r=0.590, p,0.001) and a very weak correlation with IFN-c
to PPD (r=0.292, p=0.026). The IL-13 responses were also
significantly correlated with BCG scar size (r=0.427, p=0.001).
We also used multiple regression analysis to be able to adjust for
confounders. For this we used data of 61 children that had
cytokine data at T5 and a positive BCG scar. IL-5 responses to
PPD at 5 months of age stayed significant after adjustment for
gender, age at BCG vaccination, birth weight, season at birth,
place of residence, maternal intestinal helminth and protozoan
infection status. IL-5: estimate (SE) =0.049 (0.019), p=0.012,
padjusted =0.012. However, IL-13 response to PPD became less
significant after adjustment. IL-13: estimate (SE) =0.057 (0.021),
p=0.010, padjusted =0.051.
The cytokine responses to PPD at older age, thus longer after
BCG vaccination were weakly associated with BCG scar size at 4
years of age (data not shown).
Discussion
The present study shows that BCG not only increases specific
adaptive responses in terms of Th1 and Th2 cytokines in response
Figure 2. Correlations between PPD and PHA-induced cytokine responses showing IFN-c (A), IL-5 (B) and IL-13 (C) before BCG
vaccination (T0), at 5 months of age (T5), at 1 year of age (T12), and at 2 years of age (T24). r=Spearman’s correlation coefficient, p=p-value.
doi:10.1371/journal.pone.0014066.g002
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responses. However, we did not find any evidence for its ability to
influence pro and anti inflammatory innate immune responses as
assessed by early IL-10 and TNF-a production in response to PPD
or by LPS.
BCG vaccination enhanced Th1 and Th2 cytokine responses to
mycobacterial antigen at 5 months of age (around 20 weeks after
vaccination) and although the elevated Th1 responses to PPD
were maintained up to 2 years of age, the Th2 responses to PPD
waned. In line with our results, several studies in Gambian and
United Kingdom infants [15,16] showed an increase in both Th1
and Th2 responses to PPD measured at 2–3 months after BCG
vaccination. With respect to the sustained Th1 responses, Lalor
and coworkers observed that in UK infants IFN-c levels in
response to PPD decreased from 3 months to 12 months after
vaccination [17]; however in our study, IFN-c responses to PPD
remained high at least until 2 years of age. This might indicate a
higher exposure to environmental mycobacteria in our study
population, which could help maintain the PPD-specific Th1
memory cells. Moreover, in our study 69% of the infants were
producing IFN-c to PPD before vaccination, which again may
reflect the high exposure of these infants to mycobacterial derived
products in utero and after birth. Early priming to mycobacteria
recorded as cord blood lymphocyte responses to PPD, has been
shown in newborns from an area in Kenya highly endemic for
tuberculosis, while in the same study US infants did not response
to PPD [18]. In agreement with a lack of early priming in areas
where exposure to tuberculosis and to environmental mycobac-
teria is low, Lalor and colleagues found no PPD-induced IFN-c in
unvaccinated infants living in the UK [15]. Furthermore, in an
older age group of schoolchildren, IFN-c production to PPD prior
to vaccination was higher in Malawi than in the UK where
exposure to environmental mycobacteria is lower [19]. However,
in addition to exposure to environmental mycobacteria, many
other factors which were not accounted for in our study could
influence the Th1 responses, such as the nutritional status [20],
genetic background [21], and strain of mycobacteria and its
relatedness to M. bovis BCG or M. tuberculosis [19]. The interesting
finding that Th2 responses are not sustained, could indicate that
the effect of BCG vaccination is different in magnitude or type
from that seen upon natural exposure to mycobacteria, which is
via the mucosa. It is also possible that IL-5 and IL-13 production is
from cells that do not develop a memory response that can be
boosted by re-exposure to mycobacteria.
With respect to adaptive immune responses, it was interesting to
note that there was some enhancement of polyclonal responses as
assessed by IFN-c and IL-5 production stimulated by PHA. The
correlations between responses to PHA and PPD were strongest at
5 months and 1 year of age but not at later age, which might
suggest that BCG can have an effect on cellular immunity beyond
that to mycobacterial antigen.
We found no significant increase in IL-10 and TNF-a responses
to PPD following BCG vaccination. It should be noted that IL-10
and TNF-a were measured at day 1 post stimulation to give us an
insight into early innate responses, which are highest in day 1
supernatants. It has been shown that mycobacteria and its
components [22] as well as PPD (our unpublished data indicates
that PPD activates TLR2 transfectants) can stimulate innate
immune responses through engagement of Toll-Like Receptors
such as TLR2 and for some, TLR4, on antigen presenting cells.
Almost all children produced IL-10 and TNF-a in response to
PPD prior to vaccination and this did not change after vaccination
with PPD. The lack of an effect of BCG on innate IL-10 and TNF-
a production was confirmed by analyzing responses to LPS. The
question whether BCG affects the maturation of innate immune
responses in vivo needs to be answered when considering the non-
specific beneficial effects of BCG. Our results of BCG vaccination
here would argue against any change in the innate IL-10 and
TNF-a responsiveness to PPD. However for a formal proof, it is
essential to identify which cells are producing the IL-10 and TNF-
a and study their dynamics at regular intervals after BCG
vaccination, in addition to assessing the expression levels of TLRs
and their downstream signaling after delivering the BCG vaccine.
In contrast to the study of Malhotra and coworkers [11], we did
not find differences between cytokine responses to PPD after BCG
vaccination in children born to helminth-infected mothers and
those born to helminth-free mothers. The reason for this
discrepancy is not clear. One possibility is that instead of
peripheral blood mononuclear cells we used whole blood cultures
which would mean that relatively lower numbers of PPD-specific
memory cells were stimulated.
In our study, B. hominis was found to be the predominant species
infecting pregnant mothers, as has been found in Indonesian
adults working in Taiwan [25]. Similar to other intestinal
protozoa, the presence of B. hominis can be associated with poor
Figure 3. Innate IL-10 and TNF-a responses to PPD (A) and LPS
(B). Levels of cytokines at T0 (before vaccination, n=147 for PPD and
n=101 for LPS), T5 (5 months of age, n=120 for PPD and n=117 for
LPS), T12 (1 year of age, n=105 for PPD and n=103 for LPS) and T24
(2 years of age, n=98 for PPD and n=97 for LPS).The horizontal lines in
the bars represent the median, with the lower 25% and upper 75%
percentiles and extended whiskers the 10% and 90% percentiles. Mann-
Whitney test: *0.05.p$0.01; **0.01.p$0.001; ***0.001.p.
doi:10.1371/journal.pone.0014066.g003
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have been few studies investigating the early priming of human
immune responses by intestinal protozoa and the impact on
responses to bystander antigens. One study by Kirch and
coworkers showed the production of IgA against Entamoeba
histolytica antigen by cord blood mononuclear cells of neonates
born to seropositive mothers, implying that in utero sensitization
by antigens from this intestinal protozoa can occur [27]. Here we
show that the presence of intestinal protozoan infection with B.
hominis as the predominant species in pregnant mothers can
dampen the innate and adaptive responses to PPD. Earlier studies
have shown that B. hominis infection can be associated with
impaired intestinal permeability [28] as well as lower total
leucocyte and neutrophil count [29]. Whether these may explain
the effect seen on the cytokine production in the present study, for
B. hominis alone or in combination with other pathogens/factors,
would need to be investigated further.
Finally, many studies examining the mechanisms behind tissue
fibrosis and remodeling have indicated the involvement of Th2
responses in pathogen or chemical induced injury [30,31], which
by stimulating collagen formation might initiate the repair
processes [32]. However the role of Th2 responses in scar
formation induced by BCG has not been studied before. Here we
show a strong association between IL-5 or IL-13 responses to PPD
early after BCG vaccination and scar formation at 4 years of age
when scar formation is thought to be stabilized. A study done by
Elliott and colleagues found that IL-5 response to culture filtrate
protein of M. tuberculosis was correlated with BCG scar size at one
year of age especially in infants from hookworm infected mothers
[12]. Here we extend the analyses, showing that Th2 responses are
indeed correlated with the scar size when it has stabilized at 4
years of age. Although this might be considered a reflection of an
overall strong immune responses to BCG vaccination, the fact that
there was not a strong correlation with PPD stimulated IFN-c
responses after vaccination, would argue for a selective role of
type-2 cytokines stimulated by BCG in scar formation. This could
mean that studies assessing scar size are looking more at an early
Th2 response induced by BCG rather than generally accepted
Th1 responses. Our finding needs to be confirmed in other studies
to allow any firm conclusions to be drawn.
In summary, this study has demonstrated the induction of both
antigen specific Th1 (long term) and Th2 (short term) cytokine
responses, with BCG scar formation associated more strongly with
a Th2 cytokine response early after vaccination. Although, the
Table 2. Cytokine production in unstimulated (medium) and in PHA, PPD, LPS-stimulated cultures.
Cytokine Time point n Medium n PHA n PPD n LPS
IL-10 T0
T5
T12
T24
146
119
105
98
3.3
(3.3–19.1)
3.3
(3.3–23.4)
3.3
(3.3–26.1)
3.3
(3.3–3.3)
147
120
105
98
84.8
(42.6–144.4)
56.4
(31.5–117.2)
58.3
(30.4–103.4)
64.7
(40.4–97.5)
147
120
105
98
48.6
(20.9–98.7)
40.3
(15.0–83.9)
38.6
(16.7–107.0)
17.5
(5.7–43.9)
101
117
103
97
348.0
(195.0–664.7)
325.4
(161.5–551.9)
357.8
(159.2–742.1)
159.2
(22.5–283.9)
TNF-a T0
T5
T12
T24
146
119
105
98
0.84
(0.84–9.7)
0.84
(0.84–4.7)
0.84
(0.84–5.2)
5.4
(0.84–24.0)
147
120
105
98
204.6
(63.9–517.3)
223.0
(78.5–492.8)
207.9
(87.8–458.5)
176.6
(58.7–448.3)
147
120
105
98
308.9
(122.2–925.6)
243.9
(126.1–587.8)
193.5
(98.5–356.2)
125.8
(53.3–484.5)
101
117
103
97
3528.8
(1651.5–5808.7)
3054.3
(1821.2–5671.1)
3553.2
(1794.0–6075.0)
1312.9
(709.2–2173.2)
IFN-c T0
T5
T12
T24
142
119
103
97
1.8
(1.8–21.8)
7.9
(1.8–40.6)
6.6
(1.8–31.0)
1.8
(1.8–1.8)
143
119
103
97
92.2
(35.2–239.3)
110.0
(41.2–265.6)
116.9
(41.3–258.7)
283.7
(89.4–840.8)
143
119
103
97
38.2
(4.3–105.6)
204.3
(72.1–504.1)
132.1
(40.0–245.6)
355.3
(63.0–983.5)
IL-5 T0
T5
T12
T24
142
119
103
97
2.4
(1.0–8.6)
2.4
(1.0–7.5)
1.0
(1.0–6.1)
1.0
(1.0–8.1)
143
119
103
97
713.0
(223.1–1636.0)
554.9
(295.7–1421.4)
825.4
(430.3–2000.0)
793.5
(262.2–1575.9)
143
119
103
97
5.96
(1.0–16.5)
64.7
(19.3–226.6)
27.2
(8.4–104.4)
19.9
(1.0–54.5)
IL-13 T0
T5
T12
T24
142
119
103
97
6.3
(6.3–6.3)
6.3
(6.3–13.4)
6.3
(6.3–15.4)
6.3
(6.3–6.3)
143
119
103
97
497.5
(254.6–1164.6)
331.3
(157.0–803.0)
272.5
(150.5–645.6)
435.9
(139.3–1033.4)
143
119
103
97
6.3
(6.3–20.3)
31.0
(14.0–106.6)
20.8
(6.3–48.8)
6.3
(6.3–33.2)
T0: before vaccination (2 months of age), T5: 5 months of age, T12: 1 year of age, T24: 2 years of age. All cytokine levels are expressed in median and interquartile range.
doi:10.1371/journal.pone.0014066.t002
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Cytokine Time n IH+ nI H - p nI P + nI P - p
IL-10 T0
T5
T12
T24
51
39
34
35
39.0
(14.9–83.6)
30.6
(13.3–66.3)
34.7
(14.5–124.4)
22.1
(10.8–57.9)
88
75
64
62
50.6
(25.4–103.7)
48.3
(15.2–93.6)
45.2
(20.4–120.8)
15.2
(3.3–37.5)
0.104
0.303
0.485
0.102
39
32
23
27
25.6
(12.5–49.4)
17.2
(10.1–45.7)
27.8
(12.1–81.3)
20.4
(3.3–45.1)
100
82
75
70
62.5
(25.6–116.3)
52.8
(19.2–95.4)
49.3
(22.5–124.9)
17.4
(6.5–44.0)
0.002
0.002
0.071
0.942
TNF-a T0
T5
T12
T24
51
39
34
35
200.5
(84.8–885.5)
184.0
(119.1–537.8)
237.4
(126.3–379.0)
160.2
(40.3–826.4)
88
75
64
62
335.7
(149.0–930.1)
287.6
(126.1–682.1)
177.1
(86.3–383.8)
119.7
(55.2–401.9)
0.228
0.348
0.438
0.583
39
32
23
27
199.5
(77.0–502.5)
158.9
(78.4–393.3)
124.1
(42.3–195.3)
60.2
(30.8–139.0)
100
82
75
70
359.4
(148.6–1093.7)
282.2
(136.6–784.3)
243.0
(119.8–484.8)
163.8
(80.0–540.6)
0.005
0.020
0.011
0.002
IFN-c T0
T5
T12
T24
51
38
34
35
21.3
(1.8–93.5)
159.5
(69.9–379.1)
114.5
(40.2–263.1)
563.9
(128.4–1143.0)
85
75
63
61
50.2
(7.4–111.4)
210.3
(71.3–601.0)
158.1
(42.5–253.9)
273.8
(51.1–900.0)
0.084
0.470
0.728
0.104
39
31
22
27
18.3
(1.8–102.6)
140.0
(52.2–319.2)
163.9
(58.0–288.0)
171.0
(49.6–1057.5)
97
82
75
69
48.4
(7.1–116.0)
234.8
(87.9–685.9)
132.1
(34.1–243.8)
360.8
(77.6–983.6)
0.131
0.036
0.453
0.483
IL-5 T0
T5
T12
T24
51
38
34
35
5.1
(1.0–16.4)
61.5
(12.4–276.8)
57.9
(15.8–161.6)
19.9
(1.0–63.6)
85
75
63
61
6.5
(1–16.8)
66.5
(22.9–213.6)
22.3
(7.3–72.1)
18.9
(1–54.5)
0.681
0.784
0.026
0.618
39
31
22
27
6.6
(1.0–17.1)
47.9
(16.9–242.7)
28.3
(10.9–81.9)
13.5
(1.0–46.1)
97
82
75
69
6.1
(1.0–16.5)
69.2
(20.6–228.7)
28.2
(8.4–133.0)
22.1
(1.0–66.3)
0.726
0.890
0.990
0.185
IL-13 T0
T5
T12
T24
51
38
34
35
6.3
(6.3–18.9)
37.7
(6.3–113.6)
22.1
(6.3–58.7)
6.3
(6.3–42.6)
85
75
63
61
6.3
(6.3–20.4)
30.5
(14.1–104.9)
20.8
(6.3–48.8)
6.3
(6.3–31.7)
0.980
0.612
0.512
0.863
39
31
22
27
6.3
(6.3–15.3)
25.3
(6.3–86.9)
9.8
(6.3–46.8)
6.3
(6.3–22.3)
97
82
75
69
6.3
(6.3–22.8)
33.0
(16.8–116.7)
24.1
(6.3–51.2)
6.3
(6.3–34.2)
0.032
0.190
0.263
0.256
IH: intestinal helminth, IP: intestinal protozoa. T0: before vaccination (2 months of age), T5: 5 months of age, T12: 1 year of age, T24: 2 years of age. P values in bold:
significant if ,0.05. All cytokine levels are expressed in median and interquartile range.
doi:10.1371/journal.pone.0014066.t003
Figure 4. Correlations between PPD-stimulated adaptive cytokine responses and BCG scar size at 5 months of age. IL-5 (A) and IFN-
c (B) responses to PPD and BCG scar size. Open dots represent individuals with BCG scar ,2 mm, closed dots represent those with BCG scar
.=2 mm. N=58 children. r= Spearman’s correlation coefficient, p=p-value.
doi:10.1371/journal.pone.0014066.g004
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PLoS ONE | www.plosone.org 8 November 2010 | Volume 5 | Issue 11 | e14066innate IL10 and TNF-a responses were not affected by BCG
vaccination, there was some indication of enhancement of
adaptive responses beyond PPD after vaccination. These studies
need to be taken further by a more in- depth analysis of the
immunological changes at the innate and the adaptive immune
system in order to be able to understand the non-specific effects of
BCG on mortality and morbidity found in epidemiological studies.
Supporting Information
Table S1 Cytokine responses to PPD in children born to
mothers either co-infected with intestinal helminths and protozoa
or negative for both.
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